Senior insider sale
LIGAND PHARMACEUTICALS INC — senior position signals high conviction
$1.71M
10K shares
What this filing means
ARYEH JASON plans to sell 10K shares of LIGAND PHARMACEUTICALS INC valued at approximately $1.71M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/23/2025ACC: 0001950047-25-007467
10K
Shares to sell
$1.71M
Approx. market value
10K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months6
Restricted Stock
Not Applicable
6/6/2025
1.25KRestricted Stock
Not Applicable
6/9/2024
1.14KExercised Shares
Cash
4/30/2024
2.36KExercised Shares
Cash
3/5/2024
2.89KRestricted Stock
Not Applicable
6/9/2023
1.72KRestricted Stock
Not Applicable
6/4/2022
630.00Total acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/6/2025 | Restricted Stock Not Applicable | 1.25K | — |
6/9/2024 | Restricted Stock Not Applicable | 1.14K | — |
4/30/2024 | Exercised Shares Cash | 2.36K | — |
3/5/2024 | Exercised Shares Cash | 2.89K | — |
6/9/2023 | Restricted Stock Not Applicable | 1.72K | — |
6/4/2022 | Restricted Stock Not Applicable | 630.00 | — |
| Total | 10K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
10K
Market value
$1.71M
9/23/2025
Total
Units
10K
Value
$1.71M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/23/2025 | 10K | $1.71M | NASDAQ | Planned |
| Total | 10K | $1.71M | ||